Author

Kao JH

13 يونيو 2020
الافتتاحية: زيادة عبء مرض الكبد الدهني غير الكحولي - دعوة للعمل. رد المؤلفين
Summary No abstract available. Countries: Singapore, South Korea

Read More
4 مارس 2020
نمذجة عبء مرض الكبد الدهني غير الكحولي في أربع مناطق آسيوية -2019-2030
Summary Background Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) account for an increasing proportion of liver disease in the Asia-Pacific region. Many areas in the region are experiencing epidemics of metabolic syndrome among rapidly ageing populations. Aims To estimate using modelling the growth in NAFLD populations, including cases with significant fibrosis that are […]

Read More
30 أكتوبر 2017
استراتيجيات لإدارة عبء مرض عدوى فيروس التهاب الكبد C - المجلد 4
Summary The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-“WHO Targets” (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) […]

Read More
30 أكتوبر 2017
عبء المرض الحالي والمستقبلي لعدوى فيروس التهاب الكبد C مع نموذج العلاج الحالي: المجلد 4
Summary Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and […]

Read More
30 أكتوبر 2017
الوبائيات التاريخية لفيروس التهاب الكبد C في بلدان مختارة - المجلد 4
Summary Due to the introduction of newer, more efficacious treatment options, there is a pressing need for policy makers and public health officials to develop or adapt national hepatitis C virus (HCV) control strategies to the changing epidemiological landscape. To do so, detailed, country-specific data are needed to characterize the burden of chronic HCV infection. […]

Read More